1. Home
  2. LSTA vs ICMB Comparison

LSTA vs ICMB Comparison

Compare LSTA & ICMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

BUY

Current Price

$1.00

Market Cap

15.9M

Sector

Health Care

ML Signal

BUY

Logo Investcorp Credit Management BDC Inc.

ICMB

Investcorp Credit Management BDC Inc.

BUY

Current Price

$0.70

Market Cap

17.2M

Sector

Finance

ML Signal

BUY

Company Overview

Basic Information
Metric
LSTA
ICMB
Founded
1980
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Misc Health and Biotechnology Services
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
15.9M
17.2M
IPO Year
2000
2013

Fundamental Metrics

Financial Performance
Metric
LSTA
ICMB
Price
$1.00
$0.70
Analyst Decision
Hold
Analyst Count
2
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 78.9K
32.3K
Earning Date
11-05-2026
11-11-2026
Dividend Yield
N/A
★ 21.53%
EPS Growth
★ 20.42
N/A
EPS
N/A
★ N/A
Revenue
★ $35,283,868.00
N/A
Revenue This Year
N/A
$5.32
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 56.90
N/A
52 Week Low
$0.96
$0.62
52 Week High
$5.07
$3.12

Technical Indicators

Market Signals
Indicator
LSTA
ICMB
Relative Strength Index (RSI) 34.39 44.16
Support Level $0.99 $0.65
Resistance Level $1.28 $0.88
Average True Range (ATR) 0.10 0.06
MACD -0.00 0.00
Stochastic Oscillator 11.02 54.31

Price Performance

Historical Comparison
LSTA
ICMB

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

About ICMB Investcorp Credit Management BDC Inc.

Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). The investment objective of the company is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.

Share on Social Networks: